Looking for CALR mutations in familial myeloproliferative neoplasms

被引：18
|
作者：
Maffioli, M. [1 ]
Genoni, A. [2 ]
Caramazza, D. [1 ]
Mora, B. [1 ]
Bussini, A. [2 ]
Merli, M. [1 ]
Giorgino, T. [3 ]
Casalone, R. [2 ]
Passamonti, F. [1 ]
机构：
[1] Univ Hosp Osped Circolo & Fdn Macchi, Dept Med, Div Hematol, Varese, Italy
[2] Univ Hosp Osped Circolo & Fdn Macchi, Med Genet & Cytogenet Lab, Genet Unit, SSD,SMEL, Varese, Italy
[3] Natl Res Council Italy ISIB CNR, Inst Biomed Engn, Padua, Italy
来源：
LEUKEMIA | 2014年 / 28卷 / 06期
关键词：
ESSENTIAL THROMBOCYTHEMIA; POLYCYTHEMIA-VERA; TET2; GENE; MYELOFIBROSIS; JAK2; DISORDERS;
D O I：
10.1038/leu.2014.33
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1357 / 1360
页数：5
相关论文
共 50 条
  • [21] Bioinformatic analyses of CALR mutations in myeloproliferative neoplasms support a role in signaling
    L Eder-Azanza
    D Navarro
    P Aranaz
    F J Novo
    N C P Cross
    J L Vizmanos
    Leukemia, 2014, 28 : 2106 - 2109
  • [22] Molecular heterogeneity of familial myeloproliferative neoplasms revealed by analysis of the commonly acquired JAK2, CALR and MPL mutations
    Langabeer, Stephen E.
    Haslam, Karl
    Linders, Jennifer
    Percy, Melanie J.
    Conneally, Eibhlin
    Hayat, Amjad
    Hennessy, Brian
    Leahy, Maeve
    Murphy, Karen
    Murray, Margaret
    Ainle, Fionnuala Ni
    Thornton, Patrick
    Sargent, Jeremy
    FAMILIAL CANCER, 2014, 13 (04) : 659 - 663
  • [23] Targeting the CALR interactome in myeloproliferative neoplasms
    Pronier, Elodie
    Cifani, Paolo
    Merlinsky, Tiffany R.
    Berman, Katharine Barr
    Somasundara, Amritha Varshini Hanasoge
    Rampal, Uraajit K.
    LaCava, John
    Wei, Karen E.
    Pastore, Friederike
    Maag, Jesper L., V
    Park, Jane
    Koche, Richard
    Kentsis, Alex
    Levine, Ross L.
    JCI INSIGHT, 2018, 3 (22):
  • [24] CALR mutation characterization in myeloproliferative neoplasms
    Bilbao-Sieyro, Cristina
    Florido, Yanira
    Teresa Gomez-Casares, Maria
    ONCOTARGET, 2016, 7 (33) : 52614 - 52617
  • [25] Molecular heterogeneity of familial myeloproliferative neoplasms revealed by analysis of the commonly acquired JAK2, CALR and MPL mutations
    Stephen E. Langabeer
    Karl Haslam
    Jennifer Linders
    Melanie J. Percy
    Eibhlin Conneally
    Amjad Hayat
    Brian Hennessy
    Maeve Leahy
    Karen Murphy
    Margaret Murray
    Fionnuala Ni Ainle
    Patrick Thornton
    Jeremy Sargent
    Familial Cancer, 2014, 13 : 659 - 663
  • [26] CALR-mutated myeloproliferative neoplasms
    Bellani, Valentina
    Mora, Barbara
    Iurlo, Alessandra
    Passamonti, Francesco
    LEUKEMIA & LYMPHOMA, 2025,
  • [27] Clinical Validation of a Multipurpose Assay for Detection and Genotyping of CALR Mutations in Myeloproliferative Neoplasms
    Mehrotra, Meenakshi
    Luthra, Rajyalakshmi
    Singh, Rajesh R.
    Barkoh, Bedia A.
    Galbincea, John
    Mehta, Pramod
    Goswami, Rashmi S.
    Jabbar, Kausar J.
    Loghavi, Sanam
    Medeiros, L. Jeffrey
    Verstovsek, Srdan
    Patel, Keyur P.
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2015, 144 (05) : 746 - 755
  • [28] Profile of Calreticulin (CALR) Somatic Mutations in a Cohort of Pakistani Patients with Myeloproliferative Neoplasms
    Ahmed, Rifat Zubair
    Rashid, Munazza
    Ahmed, Shariq
    Nadeem, Muhammad
    Ahmed, Nuzhat
    Shamsi, Tahir
    BLOOD, 2015, 126 (23)
  • [29] CALR mutations in myeloproliferative neoplasms affect chaperone function and differentially impact on client proteins
    Schurch, Patrick
    Lakkaraju, A.
    Malinovska, L.
    Wildschut, T.
    Lysenko, V.
    Aguzzi, A.
    Picotti, P.
    Theocharides, A.
    SWISS MEDICAL WEEKLY, 2019, 149 : 25S - 25S
  • [30] Capricious CALR mutated clones in myeloproliferative neoplasms
    Haslam, Karl
    Conneally, Eibhlin
    Langabeer, Stephen E.
    BLOOD CELLS MOLECULES AND DISEASES, 2016, 57 : 110 - 111
12345